1 Data were analyzed based on intention to treat.
2 Data were analyzed between August 2016 and April 2017.
3 Data were analyzed between October 8, 2014, and September 12,
4 Data were analyzed by linear mixed models or generalized line
5 DATA EXTRACTION: Extracted
data were analyzed by pairwise and network meta-analysis.
6 Data were analyzed by using analysis of variance, t test, or
7 Data were analyzed by Wilcoxon, Mann-Whitney U, and permutati
8 However, variations in degree of overlap were noted when
data were analyzed by year.
9 Data were analyzed for postoperative outcomes and the impact
10 Whole genome sequencing
data were analyzed for rare pLoF variants (frequency <0.1%) i
11 Data were analyzed for the present study from July 1 to Augus
12 Data were analyzed for the present study from October 6, 2016
13 Data were analyzed for thematic content from June 2015 to Apr
14 Data were analyzed from 14,841 viral hepatitis-negative adult
15 Data were analyzed from 249 patients with uveitis who had the
16 Data were analyzed from 66 registered units in 23 countries.
17 Data were analyzed from 75 000 participants in the 2013 Natio
18 Data were analyzed from December 2015 to May 2017.
19 Data were analyzed from February 1 to May 14, 2016.
20 Data were analyzed from February 18, 2016, through June 22, 2
21 Data were analyzed from February 2 to September 15, 2016.
22 The
data were analyzed from February to December 2016.
23 Longitudinal
data were analyzed from human immunodeficiency virus (HIV)-in
24 Data were analyzed from January 1 to March 31, 2016.
25 Data were analyzed from January 1, 2000, to October 27, 2011,
26 Data were analyzed from July 1, 2016, to February 24, 2017.
27 Data were analyzed from July 16 to December 7, 2015.
28 Data were analyzed from June 28, 2014, to October 24, 2016.
29 Data were analyzed from November 1, 2014, through November 21
30 Data were analyzed from November 1, 2015, to October 1, 2016.
31 Data were analyzed from October 1 through November 30, 2016.
32 The
data were analyzed from September 2014 to November 2015.
33 Data were analyzed from the 2002-2012 National Inpatient Samp
34 Surgical
data were analyzed in a subgroup of eyes with microcystoid ma
35 The MS
data were analyzed in conjunction with redox conditions and i
36 Data were analyzed in November and December 2016.
37 Data were analyzed individually and combined with the use of
38 Data were analyzed on a per-protocol and intention-to-treat (
39 METHODS AND
Data were analyzed on all PCI-CABG procedures performed in En
40 o Nanostring human v2 miRNA microarray array and expression
data were analyzed on nSolver analysis software.
41 Data were analyzed using a Microsoft Excel database.
42 post study was conducted from June 2014 to August 2015, and
data were analyzed using a mixed methods approach.
43 The
data were analyzed using a multivariate method of pattern rec
44 Data were analyzed using multiple logistic regression models
45 rformed through an inductive and iterative process, and the
data were analyzed using NVivo 10.0.
46 PET
data were analyzed using plasma and reference tissue-based me
47 Dynamic PET
data were analyzed using the validated two-tissue compartment
48 The
data were analyzed using univariate liability threshold model
49 Data were analyzed with flexible parametric survival models t
50 Data were analyzed with the Student t test and Pearson correl